Enzyme (serine/threonine protein kinase; EC 2.7.11.1), Protein kinase superfamily member (NEK family), Cell-cycle–related kinase family (NIMA-related kinases)
01
Overview
NIMA-related kinase 1 is a serine/threonine protein kinase of the NEK family that participates in centrosome dynamics, mitotic spindle assembly, primary cilium function, and is essential for early DNA damage response signaling, including priming of ATR and phosphorylation of Rad54. The human NEK1 kinase domain structure has been solved in apo and ATP-mimetic inhibitor-bound forms, supporting efforts to design selective inhibitors and suggesting possible use as chemo- or radiosensitizers. NEK1 is highly expressed in germ cells, has functional similarity to fungal NIMA in chromatin condensation, and its deficiency leads to defective checkpoint activation, chromosome breaks, aneuploidy, and tumor predisposition in mice. Mutations in NEK1 are associated with ciliopathies (including polycystic kidney disease), short-rib thoracic dysplasia, Mohr syndrome, and have been implicated in amyotrophic lateral sclerosis and cancers.
Other names
NEK1Kidney, anemia and testis (kat) mutant locus (mouse; historical/alias context)NIMA (never in mitosis gene A)-related kinase 1
02
Mechanism of action
ATP-competitive kinase inhibition of NEK1 (based on kinase domain structures with ATP-mimetic inhibitors; anticipated mechanism for experimental/tool inhibitors).
Chemo- or radio-sensitization via NEK1 inhibition to impair DNA damage repair signaling (proposed based on structural/functional data).
03
Biological functions
DNA damage response signaling (early responder to ionizing radiation, primes ATR and phosphorylates Rad54)Cell-cycle regulation, including centrosome disjunction and mitotic spindle assembly (family-level functions with NEK1 involvement)Primary cilium function/ciliogenesis-related processesMeiosis/germ cell biology (high expression in germ cells; functional similarity to NIMA; affects chromatin condensation when mislocalized)Maintenance of genomic stability; checkpoint activation (CHK1/CHK2) and S/G2-M arrest after damageTumor suppressor-like roles in genome stability (heterozygous Nek1 mutant mice show higher lymphoma incidence)
04
Disease associations
Ciliopathies including polycystic kidney disease (mutations in Nek1 cause PKD-like phenotypes in mice; defects linked to human PKD)Short-rib thoracic dysplasia and Mohr syndrome (mutations reported)Amyotrophic lateral sclerosis (NEK1 implicated/mutated in ALS)Cancer (mutations reported; roles in DNA damage response, potential tumor suppression; increased lymphomas in Nek1+/− mice)
05
Safety considerations
On-target toxicity risk in proliferative tissues and germ cells due to roles in DNA damage response, genomic stability, meiosis, and ciliary function (potential for infertility, genomic instability, ciliopathy-like effects)Potential hematologic or neoplastic risks if NEK1 function is chronically suppressed, given tumor suppressor-like roles in mice
06
Interacting drugs
No approved, highly selective clinical NEK1 inhibitors are established; structural studies report ATP-mimetic inhibitor binding to the NEK1 kinase domain (tool-like ligands used crystallographically)
1 more in the full profile.
07
Biomarkers
NEK1 loss-of-function or pathogenic variants as genetic biomarkers in ALS and ciliopathies (e.g., short-rib thoracic dysplasia) and PKD contextsNEK1 expression/activity or mutation status as a potential biomarker of DNA damage response competence and sensitivity to genotoxic therapy (inferred from essential role in ATR/CHK signaling)
Beyond the preview
Go deeper on NIMA-related kinase 1 (protein kinase) (NEK1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Drug pipeline
Full profile access
Explore the programs pursuing this target and their development progress.
Drug candidates
Developers
Development stage
Clinical trials
Full profile access
Follow the clinical studies evaluating therapies directed at this target.
Trial design
Status
Readouts
Competitive landscape
Full profile access
Compare approaches across drug candidates, modalities, and indications.
Programs
Modalities
Indications
Literature & evidence
Full profile access
Investigate the research and source evidence behind target biology and development.
Publications
Sources
Analysis
Patents
Full profile access
Explore patent activity around therapies and technologies addressing this target.
Patents
Assignees
Technologies
Research & analysis
Full profile access
Connect target biology, drug development, and emerging evidence in your research.
Biology
Development news
Analysis
Bring the full picture into focus.
See how Gosset can support your research on NIMA-related kinase 1 (protein kinase) (NEK1).